Waters Corporation and the Chinese Pharmacopoeia Commission (ChP) have agreed to establish a Joint Open Laboratory. Scheduled to open before the end of 2014, the new Joint Open Laboratory will focus on research of pharmacopoeia standards, development of testing methods, methods validations, and basic and advanced technical training of pharmacopoeia detection methods. Both the ChP and Waters expect the laboratory to become one of the national technical support centers in the field of Chinese pharmaceutical standards.
​Located in the laboratory building of Beijing Zhendong Guangming Drug Research Institute, the new Joint Open Laboratory is more than 400 square meters (more than 1300 square feet). The laboratory will be outfitted with a full complement of Waters chromatography and mass spectrometry technologies.